We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

149 hedge funds and large institutions have $200M invested in ImmunityBio in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 44 increasing their positions, 39 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 20

13% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 39

6% more funds holding

Funds holding: 141 → 149 (+8)

0.28% more ownership

Funds ownership: 8.67% → 8.95% (+0.28%)

5% less capital invested

Capital invested by funds: $209M → $200M (-$9.54M)

45% less call options, than puts

Call options by funds: $2.39M | Put options by funds: $4.31M

Holders
149
Holders Change
+8
Holders Change %
+5.67%
% of All Funds
2.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
44
Reduced
39
Closed
20
Calls
$2.39M
Puts
$4.31M
Net Calls
-$1.92M
Net Calls Change
+$2.51M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$3.93M
2
State Street
State Street
Massachusetts
+$3.34M
3
OIM
Oracle Investment Management
Connecticut
+$2.45M
4
Millennium Management
Millennium Management
New York
+$2.04M
5
Citadel Advisors
Citadel Advisors
Florida
+$1.9M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$1.85M
2
Citigroup
Citigroup
New York
-$1.78M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.44M
4
BlackRock
BlackRock
New York
-$1.4M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wolverine Trading
76
Wolverine Trading
Illinois
$154K +$160K +26,082 New
VEA
77
Virtus ETF Advisers
New York
$153K -$9.98K -1,626 -6%
Handelsbanken Fonder
78
Handelsbanken Fonder
Sweden
$151K – – –
VOYA Investment Management
79
VOYA Investment Management
Georgia
$147K – – –
DU
80
Delphia (USA)
Ontario, Canada
$143K +$156K +25,504 New
SW
81
SteelPeak Wealth
California
$141K +$155K +25,200 New
Simplex Trading
82
Simplex Trading
Illinois
$135K -$345K -56,312 -70%
Man Group
83
Man Group
United Kingdom
$132K +$144K +23,469 New
Two Sigma Advisers
84
Two Sigma Advisers
New York
$131K -$28.8K -4,700 -17%
Mirae Asset Global Investments
85
Mirae Asset Global Investments
South Korea
$129K +$42.3K +6,896 +43%
EFM
86
E Fund Management
China
$128K +$48.7K +7,933 +53%
Daiwa Securities Group
87
Daiwa Securities Group
Japan
$126K +$41K +6,676 +42%
State Board of Administration of Florida Retirement System
88
State Board of Administration of Florida Retirement System
Florida
$125K – – –
JF
89
Jump Financial
Illinois
$123K +$67.1K +10,940 +100%
VRS
90
Virginia Retirement Systems
Virginia
$122K +$50.9K +8,300 +61%
ASRS
91
Arizona State Retirement System
Arizona
$121K +$2.69K +439 +2%
Ensign Peak Advisors
92
Ensign Peak Advisors
Utah
$117K +$99.9K +16,290 +357%
EGM
93
Engineers Gate Manager
New York
$114K -$102K -16,673 -45%
MAM
94
Martingale Asset Management
Massachusetts
$104K +$113K +18,425 New
CIBC Asset Management
95
CIBC Asset Management
Ontario, Canada
$94K – – –
Teacher Retirement System of Texas
96
Teacher Retirement System of Texas
Texas
$92K +$9.84K +1,603 +11%
SO
97
STRS Ohio
Ohio
$86K – – –
BAM
98
Berkshire Asset Management
Pennsylvania
$84K – – –
CLOS
99
Compagnie Lombard Odier SCmA
Switzerland
$79K +$85.9K +14,000 New
Zurich Cantonal Bank
100
Zurich Cantonal Bank
Switzerland
$77K -$25.1K -4,084 -23%
2 3
4
5 6

IBRX Hedge Fund Activity: Q1 2022 in Review

149 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q1 2022, worth a combined $200M — down 4.6% from $209M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new IBRX positions and 20 closed out — a net gain of 9 holders — while 44 added to existing stakes and 39 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $3.93M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $1.85M sold.

  • 149 institutional investors held ImmunityBio (IBRX) as of Q1 2022, up from 141 in Q4 2021.
  • Funds reported $200M of ImmunityBio stock for Q1 2022, down 4.6% quarter-over-quarter.
  • 29 funds opened new ImmunityBio positions in Q1 2022 and 20 closed out, a net change of +9 holders.
  • The largest ImmunityBio buyer in Q1 2022 was Morgan Stanley, an estimated $3.93M added.
  • The largest ImmunityBio seller in Q1 2022 was Renaissance Technologies, an estimated $1.85M sold.

Based on aggregated 13F filings for Q1 2022.